Could a common gout drug ease a tough type of heart failure?
NCT ID NCT05637398
First seen Apr 29, 2026 · Last updated May 18, 2026 · Updated 4 times
Summary
This study tested whether colchicine, an anti-inflammatory drug used for gout, can reduce inflammation in people with a specific type of heart failure called HFpEF. 42 adults with heart failure symptoms and signs of inflammation took colchicine. The goal was to see if the drug lowers markers of inflammation and improves heart function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HFPEF - HEART FAILURE WITH PRESERVED EJECTION FRACTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
A Shchendrygina
Moscow, 119415, Russia
-
Anastasia Shchendrygina
Moscow, 119415, Russia
Conditions
Explore the condition pages connected to this study.